Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Journal of Medical Case Reports|April 23, 2016
Optic nerve sheath meningioma detected by single- photon emission computed tomography/computed tomography somatostatin receptor scintigraphy: a case reportLucie Nussbaum-Hermassi, Guido Ahle, Chistophe Zaenker, et al.
Cytometry. Part B, Clinical Cytometry|August 2, 2016
Cytomorphology and flow cytometry of brain biopsy rinse fluid enables faster and multidisciplinary diagnosis of large B-cell lymphoma of the central nervous systemAgathe Debliquis, Jimmy Voirin, Inès Harzallah, et al.
Onkologie|April 15, 2010
Intravascular large B-cell lymphoma presenting as dementia and hemolytic anemiaAlexander Baraniskin, Andreas Jähnert, Guido Ahle, et al.
Frontiers in Neurology|November 11, 2021
Multifocal and Microvascular Involvement in Ischemic Stroke During COVID-19: A Cohort Study With Comparison With Non-COVID-19 StrokeGeoffroy Hautecloque, Christian Kempf, Camélia Stan, et al.
Anticancer Research|July 27, 2022
Metronomic Cyclophosphamide With Cisplatin and Bevacizumab for Refractory Anaplastic Ependymoma: A Retrospective StudyXavier Choderlos DE Laclos, Didier Frappaz, Guido Ahle, et al.
Neuro-Oncology|August 8, 2015
Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for primary central nervous system lymphomaAlexander Baraniskin, Elena Zaslavska, Stefanie Nöpel-Dünnebacke, et al.
Emerging Infectious Diseases|July 18, 2018
Progressive Multifocal Leukoencephalopathy after Treatment with NivolumabMartin Martinot, Guido Ahle, Inesa Petrosyan, et al.
Chinese Clinical Oncology|March 23, 2021
High risk of recurrence for grade II meningioma: a 10-year multicenter analysis of prognosis factorsLaura Bender, François Somme, Benoît Lhermitte, et al.
Bulletin Du Cancer|March 8, 2022
[Central nervous system disorders on lorlatinib: How to detect and manage in practice?]Vincent Fallet, Pascal Rouby, Guido Ahle, et al.
Journal of Neurology|January 4, 2022
Ocrelizumab versus fingolimod after natalizumab cessation in multiple sclerosis: an observational studyKévin Bigaut, Laurent Kremer, Thibaut Fabacher, et al.
Pageof 5